Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joseph

Showing results (1021-1030 of 1,154) with videos related to

Pageof 116
Sort By:
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2017
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibodyKar Muthumani, Liron Marnin, Sagar B Kudchodkar, et al.
Plos One|February 16, 2023
Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions-A report from the "Health Equity through Diversity" seminar seriesLuiza Reopell, Timiya S Nolan, Darrell M Gray, et al.
Sexually Transmitted Diseases|July 28, 2025
Persistence of genetically related Neisseria gonorrhoeae strains causing Disseminated Gonococcal Infection (DGI) cases in southwestern Michigan during 2019 to 2023Sandeep J Joseph, Laura A S Quilter, Brian H Raphael, et al.
Nature|September 25, 2024
The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8<sup>+</sup> T cells against cancerBing Feng, Zhiliang Bai, Xiaolei Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
JCI Insight|January 12, 2018
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulationSonia Guedan, Avery D Posey, Carolyn Shaw, et al.
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Mucosal Immunology|November 12, 2015
HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genesS A Abdulhaqq, C Zorrilla, G Kang, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Pageof 116

Showing results (1021-1030 of 1,154) with videos related to

Sort By:
Pageof 116
Vaccines|February 5, 2020
Immune Therapy Targeting E6/E7 Oncogenes of Human Paillomavirus Type 6 (HPV-6) Reduces or Eliminates the Need for Surgical Intervention in the Treatment of HPV-6 Associated Recurrent Respiratory PapillomatosisCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
Cancer Immunology, Immunotherapy : CII|August 19, 2017
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibodyKar Muthumani, Liron Marnin, Sagar B Kudchodkar, et al.
Plos One|February 16, 2023
Community engagement and clinical trial diversity: Navigating barriers and co-designing solutions-A report from the "Health Equity through Diversity" seminar seriesLuiza Reopell, Timiya S Nolan, Darrell M Gray, et al.
Sexually Transmitted Diseases|July 28, 2025
Persistence of genetically related Neisseria gonorrhoeae strains causing Disseminated Gonococcal Infection (DGI) cases in southwestern Michigan during 2019 to 2023Sandeep J Joseph, Laura A S Quilter, Brian H Raphael, et al.
Nature|September 25, 2024
The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8<sup>+</sup> T cells against cancerBing Feng, Zhiliang Bai, Xiaolei Zhou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple MyelomaShwetha H Manjunath, Adam D Cohen, Simon F Lacey, et al.
JCI Insight|January 12, 2018
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulationSonia Guedan, Avery D Posey, Carolyn Shaw, et al.
The Journal of Clinical Investigation|December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integrationChristopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Mucosal Immunology|November 12, 2015
HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genesS A Abdulhaqq, C Zorrilla, G Kang, et al.
The New England Journal of Medicine|September 10, 2015
Chimeric Antigen Receptor T Cells against CD19 for Multiple MyelomaAlfred L Garfall, Marcela V Maus, Wei-Ting Hwang, et al.
Pageof 116